WA
WestEnd Advisors Portfolio holdings
AUM
$4.03B
1-Year Return
16.84%
This Quarter Return
+9.59%
1 Year Return
+16.84%
3 Year Return
+52.53%
5 Year Return
+81.57%
10 Year Return
+163.89%
AUM
$4.03B
AUM Growth
+$265M
(+7%)
Cap. Flow
+$9.12M
Cap. Flow
% of AUM
0.23%
Top 10 Holdings %
Top 10 Hldgs %
66.86%
Holding
377
New
15
Increased
85
Reduced
148
Closed
9
Top Buys
Top Sells
| 1 |
Vanguard FTSE Pacific ETF
VPL
|
$174M |
| 2 |
Financial Select Sector SPDR Fund
XLF
|
$102M |
| 3 |
Goldman Sachs
GS
|
$57.1M |
| 4 |
Merck
MRK
|
$29.4M |
| 5 |
Health Care Select Sector SPDR Fund
XLV
|
$17M |
Sector Composition
| 1 | Technology | 7.99% |
| 2 | Financials | 3.3% |
| 3 | Communication Services | 3.28% |
| 4 | Healthcare | 2.38% |
| 5 | Consumer Discretionary | 2.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Mondelez International
MDLZ
$79.9B
| $3.17K | ﹤0.01% |
47
-1
| -2% | -$67 |
|
127
Blackrock
BLK
$170B
| $3.15K | ﹤0.01% |
3
-1
| -25% | -$1.05K |
|
128
iShares MSCI Japan Value ETF
EWJV
$490M
| $3.13K | ﹤0.01% |
90
| – | – |
|
129
Capital One
COF
$142B
| $2.98K | ﹤0.01% |
14
+2
| +17% | +$426 |
|
130
Zoetis
ZTS
$67.9B
| $2.96K | ﹤0.01% |
19
+2
| +12% | +$312 |
|
131
Accenture
ACN
$159B
| $2.69K | ﹤0.01% |
9
-1
| -10% | -$299 |
|
132
HCA Healthcare
HCA
$98.5B
| $2.68K | ﹤0.01% |
7
| – | – |
|
133
Lowe's Companies
LOW
$151B
| $2.66K | ﹤0.01% |
12
| – | – |
|
134
Colgate-Palmolive
CL
$68.8B
| $2.64K | ﹤0.01% |
29
-2
| -6% | -$182 |
|
135
Cadence Design Systems
CDNS
$95.6B
| $2.47K | ﹤0.01% |
8
-1
| -11% | -$308 |
|
136
Blackstone
BX
$133B
| $2.39K | ﹤0.01% |
16
-7
| -30% | -$1.05K |
|
137
Intercontinental Exchange
ICE
$99.8B
| $2.39K | ﹤0.01% |
13
-3
| -19% | -$550 |
|
138
Fiserv
FI
$73.4B
| $2.24K | ﹤0.01% |
13
-3
| -19% | -$517 |
|
139
CME Group
CME
$94.4B
| $2.21K | ﹤0.01% |
8
-3
| -27% | -$827 |
|
140
Applied Materials
AMAT
$130B
| $2.2K | ﹤0.01% |
12
-1
| -8% | -$183 |
|
141
Marsh & McLennan
MMC
$100B
| $2.19K | ﹤0.01% |
10
-5
| -33% | -$1.09K |
|
142
Regeneron Pharmaceuticals
REGN
$60.8B
| $2.1K | ﹤0.01% |
4
| – | – |
|
143
Cencora
COR
$56.7B
| $2.1K | ﹤0.01% |
7
+1
| +17% | +$300 |
|
144
Becton Dickinson
BDX
$55.1B
| $2.07K | ﹤0.01% |
12
+1
| +9% | +$172 |
|
145
Synopsys
SNPS
$111B
| $2.05K | ﹤0.01% |
4
-1
| -20% | -$513 |
|
146
Starbucks
SBUX
$97.1B
| $2.02K | ﹤0.01% |
22
-1
| -4% | -$92 |
|
147
Fortinet
FTNT
$60.4B
| $2.01K | ﹤0.01% |
19
| – | – |
|
148
KKR & Co
KKR
$121B
| $2K | ﹤0.01% |
15
-4
| -21% | -$532 |
|
149
Micron Technology
MU
$147B
| $1.97K | ﹤0.01% |
16
-120
| -88% | -$14.8K |
|
150
Edwards Lifesciences
EW
$47.5B
| $1.96K | ﹤0.01% |
25
+3
| +14% | +$235 |
|